Dawn of Good Health
IN THE heart of UK, there is an Indian who is making waves with his entrepreneurship and philanthropy. We are talking about Dr Nik Kotecha, who was awarded an OBE (Officer of the Most Excellent Order of the British Empire) last summer and is counted among the most dynamic personalities to have emerged in the pharmaceutical sector in the UK, in recent years. This year, his company is set to launch 12 new generic medicines in areas addressing the central nervous system, thyroid, diabetes, oncology and pain relief. The OBE honour was not bestowed on him for his work in the pharmaceutical sector through his company Morningside Pharmaceuticals alone, but also for his philanthropical contribution to society. With his wife Moni, Dr Kotecha runs the Kotecha family charitable trust called The Randal Charitable Foundation. It aims to provide adequate funds to save lives in the UK and in developing countries by preventing poverty or relieving people of it. The foundation also works in the public health domain by providing appropriate medical care to save lives. Dr Kotecha has earned several notable laurels for making quality healthcare an affordable and accessible reality across the globe. In 2012, he received the Queen’s Award for enterprise and international trade. He also accompanied Prime Minister Theresa May on her visit to India last year. May hailed Kotecha’s Morningside Pharmaceuticals as “the best of British”. She also referred to his company being a great example of what the UK can offer the world after Brexit. With so much being said and done already, it seems like Dr Kotecha would play a key role in R&D (Research and Development) partnerships between India and UK, apart from bringing shared opportunities for investment with respect to Indian pharmaceutical and clinical organisations.